TP53 and B-cell chronic lymphocytic leukemia: The International Prognostic Index for CLL (CLL-IPI) was calculated for 55 patients for whom we possessed complete data (age at diagnosis, Binet stage, serum β2-microglobulin, IGHV mutational status, and TP53 aberrations (mutations of TP53 and/or del17p)).